Yes, COVID-19 can make your eyes water. Watery eyes rank among the most commonly reported ocular symptoms of SARS-CoV-2 infection, typically appearing alongside redness, irritation, and light sensitivity. The tearing is usually mild, self-limiting, and driven by inflammation of the ocular surface rather than by emotion or allergy. It most often accompanies other COVID symptoms and rarely appears as the only sign of infection.
The mechanism is worth understanding because it explains why some people tear for days while others notice nothing at all. Three systems converge on the same endpoint: the lacrimal glands that produce tears, the sensory nerves that trigger reflex tearing, and the drainage channels that clear fluid from the eye surface.
The lacrimal functional unit and viral inflammation
The eye's tear system is not just a pair of glands. Ophthalmologists describe a "lacrimal functional unit" that includes the main and accessory lacrimal glands, the conjunctiva, the corneal surface, the meibomian glands in the eyelids, and the sensory and motor nerves connecting them. These components work as a reflex loop. Irritation anywhere on the surface sends signals through the trigeminal nerve, and the lacrimal glands respond by increasing output.
SARS-CoV-2 can disturb this loop at several points. The virus enters cells through the ACE2 receptor, which is expressed in the conjunctiva and in the lacrimal gland tissue. When the virus binds there, local immune cells release inflammatory signaling molecules, including interleukins and tumor necrosis factor. That inflammation makes the ocular surface more sensitive and can push the lacrimal glands into oversection. The result is reflex tearing that has nothing to do with crying.
A second pathway runs through the nasolacrimal drainage system. Tears normally drain through small openings in the inner eyelids, down the nasolacrimal duct, and into the nose. When the nasal lining swells during COVID, that duct can become partially blocked. Tears that would otherwise drain away instead spill onto the cheek. This is the same reason a bad cold makes eyes water, and it explains why watery eyes often track with nasal congestion.
A third pathway involves the eyelids themselves. Meibomian glands secrete the oily outer layer of the tear film that slows evaporation. Inflammation can disrupt that oil layer, leaving tears that evaporate too quickly. The eye responds by producing more reflex tears, which are watery and low in oil, creating a cycle of tearing and dryness at the same time.
In plain terms: the eye can water because the glands overproduce, because the drain is blocked, or because the tear film is unstable. COVID can trigger all three.
How common is watery eye with COVID?
Quantifying ocular symptoms is harder than it sounds because studies use different definitions. Some count only conjunctivitis diagnosed by a clinician. Others count any self-reported eye symptom. That variation explains why reported rates differ widely across reviews.
Large systematic reviews and meta-analyses of COVID-19 patients have generally found ocular symptoms in a minority of cases, with conjunctivitis and watery eyes among the most frequently listed. Estimates across pooled studies have ranged from roughly one in twenty patients to as high as one in four, depending on the population and the definition used. Watery eyes specifically tends to appear at similar or slightly higher frequency than conjunctivitis itself, because tearing can occur without visible redness.
Timing matters too. Ocular symptoms most often appear within the first days of systemic illness, alongside fever, cough, and fatigue. In some patients they appear concurrently with respiratory symptoms; less commonly they are the presenting complaint. Isolated watery eyes without any other symptom is unusual but documented.
The practical takeaway is that watery eyes are a plausible but nonspecific COVID symptom. They are far less diagnostic than loss of smell or taste, and they overlap heavily with allergies, dry eye, and the common cold.
Timeline: how COVID-related eye watering unfolds
| Stage | Typical timing | What is happening | What most people notice |
|---|---|---|---|
| Exposure and incubation | Days 0–5 after exposure | Virus binds ACE2 receptors on conjunctiva and nasal mucosa | Nothing, or mild itch |
| Early systemic phase | Days 1–4 of symptoms | Inflammatory cytokines rise; nasal swelling begins | Watery eyes with fever, cough, or congestion |
| Peak ocular phase | Days 2–7 | Reflex tearing and drainage blockage peak together | Visible tearing, redness, light sensitivity |
| Recovery phase | Days 7–14 | Inflammation subsides; tear film rebalances | Tearing fades, occasional dryness remains |
| Post-illness phase | Weeks 2–8 | Meibomian glands and tear film recover slowly | Intermittent dryness or grittiness |
| Persistent cases | Beyond 8 weeks | Unstable tear film, gland dysfunction | Dryness rather than tearing in most cases |
The pattern matters because it separates COVID tearing from allergic tearing. Allergy tends to produce intense itch and bilateral watering within minutes of exposure and resolves with antihistamines. COVID tearing builds over days alongside systemic symptoms and does not respond to allergy medication.
When watery eyes signal something more serious
Most COVID-related tearing is benign. A small number of patients develop conjunctivitis that warrants evaluation, and rarely, ocular inflammation extends deeper. The professional caveat here is that eye symptoms in a person with COVID are usually not the main problem, and clinicians should not anchor on them. But certain features change the risk profile.
Watch for these red flags:
Severe eye pain, especially pain with eye movement, which can indicate orbital or deeper inflammation. Vision loss or a marked drop in clarity that does not clear with blinking. Copious thick discharge, especially yellow or green, suggesting bacterial superinfection rather than viral tearing. Marked swelling, redness, or proptosis (eye bulging), which can signal orbital cellulitis. Persistent symptoms beyond two weeks that worsen rather than improve. Eye symptoms in someone with a history of autoimmune disease or recent eye surgery.
These features are uncommon. Their value is in triage: they separate a self-limited viral irritation from conditions that need prompt ophthalmic assessment.
Misconceptions about COVID and eye watering
Several assumptions circulate that the evidence does not support.
The first is that watery eyes mean you have COVID. They do not. Watery eyes are common in allergic rhinitis, dry eye disease, viral colds, and irritant exposure. In isolation they carry very low diagnostic weight. A positive test, not a symptom, confirms infection.
The second is that COVID tears are contagious in a meaningful way. SARS-CoV-2 RNA has been detected in conjunctival secretions, but live virus isolation from tears is rare. The dominant transmission route remains respiratory droplets and aerosols. Tearing is a symptom, not a major transmission pathway.
The third, and the counterintuitive one, is that watery eyes and dry eye are not opposites in COVID. They often coexist. Inflammation destabilizes the tear film, so the eye alternates between reflex tearing and a gritty, dry sensation. Patients who report "watery but dry" eyes are describing a real physiological state, not a contradiction.
The fourth misconception is that eye symptoms predict severe COVID. Current evidence does not support ocular symptoms as a reliable severity marker. Some studies have suggested associations in either direction, and the findings are inconsistent. Ocular involvement reflects local inflammation, not necessarily systemic disease burden.
A fifth assumption worth correcting: artificial tears are not a treatment for COVID. They relieve surface irritation and improve comfort, but they do not shorten infection or prevent transmission. Symptom relief and disease modification are different claims.
Comparison: COVID tearing versus other causes of watery eyes
| Feature | COVID-related tearing | Allergic tearing | Dry eye reflex tearing | Viral cold tearing |
|---|---|---|---|---|
| Itch | Mild or absent | Prominent | Variable | Mild |
| Redness | Common | Common | Mild | Common |
| Discharge | Watery, occasionally mild mucus | Clear and stringy | None or minimal | Watery to mucoid |
| Timing | Days into systemic illness | Minutes after exposure | Worse later in day | Alongside congestion |
| Bilateral | Usually | Almost always | Usually | Usually |
| Response to antihistamine | None | Good | None | None |
| Duration | 1–2 weeks | Hours to days | Chronic, fluctuating | 1–2 weeks |
This table is a guide, not a diagnostic tool. Overlap is common, and only testing confirms COVID.
Practical steps for managing COVID-related eye watering
Most cases need no special treatment. The goal is comfort and avoiding secondary irritation.
First, use preservative-free artificial tears up to four to six times daily if the eyes feel gritty or irritated. Preservative-free formulations matter because frequent use of preserved drops can irritate an already inflamed surface, particularly beyond four doses per day.
Second, apply a warm compress to closed eyelids for five to ten minutes once or twice daily. This softens meibomian gland secretions and supports the oil layer of the tear film. It is low-risk and often improves the watery-dry paradox.
Third, reduce evaporative stress. Lower screen brightness, take breaks from screens every twenty minutes, and avoid direct air from fans or heating vents. These measures do not treat infection but reduce surface irritation that drives reflex tearing.
Fourth, avoid contact lenses until symptoms resolve. The conjunctiva is inflamed, and lens wear adds mechanical and microbial risk. Most eye care professionals recommend waiting until tearing and redness have been gone for several days.
Fifth, do not rub the eyes. Rubbing amplifies inflammation and, in rare cases, can contribute to corneal surface damage. If itch is significant, cool compresses are safer than rubbing.
Sixth, seek evaluation if red flags appear or if symptoms persist beyond two weeks without improvement.
For most people, these steps are sufficient. The tearing resolves as systemic inflammation fades.
Limits of the evidence and what remains uncertain
The honest position is that COVID-related eye watering is well described but under-studied at the mechanistic level. Much of what is known comes from case series and observational studies rather than controlled trials. The pathways described here, ACE2 expression, cytokine-driven inflammation, nasolacrimal obstruction, and tear film instability, are biologically plausible and consistent with clinical observation. They are not fully mapped for SARS-CoV-2 specifically.
Reported prevalence varies widely because studies define ocular symptoms differently and because many rely on self-report. Studies that use standardized ophthalmic examination tend to find lower rates than those based on questionnaires. Neither is wrong; they measure different things.
It is also unclear how much of the tearing attributed to COVID is actually caused by co-circulating viruses, seasonal allergens, or dry indoor air during the same period. Without baseline data, attribution is imperfect.
What can be said with confidence is limited but useful. Watery eyes are a recognized, usually mild ocular symptom of COVID-19. They arise from inflammation and drainage changes rather than from a single mechanism. They overlap with many other conditions and carry little diagnostic value on their own. Red flags are rare but worth knowing. And for the great majority of people, the symptom resolves without specific treatment.